Silverback Therapeutics (SBTX) News Today $5.21 +0.26 (+5.25%) (As of 12/4/2023 ET) Add Compare Share Share Today's Range$4.94▼$5.2150-Day Range$3.38▼$5.2152-Week Range$2.80▼$8.97Volume731,988 shsAverage Volume337,931 shsMarket Capitalization$187.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRoyce & Associates LP Invests $1.98 Million in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - September 13 at 10:43 AMSR One Capital Management LP Purchases 1,003,226 Shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - August 11 at 5:39 PMLevin Capital Strategies L.P. Boosts Stake in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - July 7 at 12:28 PMVontobel Holding Ltd. Raises Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - June 29 at 4:35 AMCitigroup Inc. Boosts Stock Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - June 2 at 5:16 AMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Shares Sold by K2 Principal Fund L.P.marketbeat.com - May 26 at 2:51 PMARS Pharmaceuticals Inc (SPRY)uk.investing.com - May 11 at 1:32 PMErgoteles LLC Has $394,000 Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - March 3 at 5:33 AMRubric Capital Management LP Has $14.23 Million Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX)marketbeat.com - February 17 at 11:48 AMSPRY ARS Pharmaceuticals, Inc.seekingalpha.com - January 24 at 8:04 PMARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger247wallst.com - November 22 at 6:29 AMDr. Sarina Tanimoto Discloses Position in SBTX / Silverback Therapeuticsnasdaq.com - November 18 at 8:19 PMARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxisfinance.yahoo.com - November 10 at 6:41 PMARS Pharmaceuticals Closes Merger with Silverback Therapeuticsfinance.yahoo.com - November 8 at 5:59 PMSilverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic Reactionsmarkets.businessinsider.com - October 28 at 8:15 AMSilverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxisfinance.yahoo.com - October 21 at 7:59 AMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Up 83.5% in Septembermarketbeat.com - October 14 at 7:19 PMINVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBTmarkets.businessinsider.com - September 17 at 5:10 AMSBTX Silverback Therapeutics, Inc.seekingalpha.com - September 15 at 10:58 PMSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBTmarkets.businessinsider.com - September 6 at 11:53 AMSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYmarkets.businessinsider.com - August 23 at 6:32 PMSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTXapnews.com - August 17 at 12:02 PMSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTXapnews.com - August 11 at 1:33 AMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Sees Significant Decrease in Short Interestmarketbeat.com - July 31 at 2:50 AMSHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigationsmorningstar.com - July 30 at 7:00 AMINVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZYapnews.com - July 28 at 2:21 AMShareholder Alert - The M&A Class Action Firm Announces the Investigation of Silverback Therapeutics, Inc. - SBTXbenzinga.com - July 27 at 9:21 PMLifshitz Law PLLC Announces Investigation of IEA, ZY, SBTX, and HNGRapnews.com - July 26 at 9:07 PMSilverback Therapeutics plans merger with San Diego biotechfinance.yahoo.com - July 26 at 11:07 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, SBTX, Uapnews.com - July 25 at 1:43 PMSILVERBACK THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SBTX and Encourages Investors to Contact the Firmbenzinga.com - July 22 at 11:04 PMSHAREHOLDER ALERT: Weiss Law Investigates Silverback Therapeutics, Inc.prnewswire.com - July 22 at 8:30 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, ONEM, SBTX, ZENapnews.com - July 22 at 1:04 PMOnce A Cancer Company, Silverback Merges With Small Biotech Working On Allergy Treatmentfinance.yahoo.com - July 22 at 1:04 PMSilverback Therapeutics Shares Down After Merger Newsmarketwatch.com - July 22 at 8:03 AMSilverback Therapeutics to merge with San Diego biotech company developing EpiPen alternativemsn.com - July 22 at 8:03 AMSBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to Shareholdersbenzinga.com - July 21 at 9:02 PMSilverback Therapeutics and ARS Pharmaceuticals Announce Mergerfinance.yahoo.com - July 21 at 9:02 PMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 32.4% in Junemarketbeat.com - July 17 at 5:03 AMWhat You Need To Know About Silverback Therapeutics, Inc.'s (NASDAQ:SBTX) Investor Compositionfinance.yahoo.com - June 22 at 4:28 PMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 16.5% in Maymarketbeat.com - June 17 at 7:17 AMSilverback Therapeutics (NASDAQ:SBTX) Stock Rating Lowered by Zacks Investment Researchmarketbeat.com - June 1 at 5:01 AMSilverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - May 17 at 4:11 PMSilverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Up 35.2% in Aprilmarketbeat.com - May 16 at 8:36 AMSilverback Therapeutics (NASDAQ:SBTX) Price Target Cut to $5.00 by Analysts at Stifel Nicolausmarketbeat.com - May 13 at 4:00 PMSilverback Therapeutics GAAP EPS of -$0.70 misses by $0.03seekingalpha.com - May 12 at 5:40 PMSilverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 12 at 5:40 PMIs Silverback Therapeutics (NASDAQ:SBTX) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - May 8 at 1:23 PMSilverback Therapeutics (NASDAQ:SBTX) Upgraded to "Buy" at Zacks Investment Researchmarketbeat.com - April 6 at 6:19 AMGoldman Sachs Downgrades Silverback Therapeutics to Neutral, Lowers Price Target to $3.5benzinga.com - April 4 at 10:02 AM Get Silverback Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Media Mentions By Week SBTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBTX News Sentiment▼0.000.70▲Average Medical News Sentiment SBTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBTX Articles This Week▼00▲SBTX Articles Average Week Get Silverback Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ZVRA News XOMA News DNTH News FHTX News RIGL News ALIM News ALT News ATXS News STOK News AKBA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:SBTX) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silverback Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.